Marie Fukutake
Overview
Explore the profile of Marie Fukutake including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kasuga Y, Kajikawa K, Ishikawa N, Ogata Y, Takahashi M, Akita K, et al.
Nutrients
. 2025 Feb;
17(3).
PMID: 39940296
: Recently, it was reported that glucose variability (GV) calculated using the 75 g oral glucose tolerance test (OGTT) is associated with adverse perinatal outcomes. However, its role in gestational...
2.
Abe Y, Ochiai D, Sato Y, Otani T, Fukutake M, Ikenoue S, et al.
Placenta
. 2021 Jan;
104:247-252.
PMID: 33461069
Even in the context of modern medicine, infants with fetal and neonatal neurological diseases such as cerebral palsy and myelomeningocele suffer serious long-lasting impairment due to the irreversible neuronal damage....
3.
Ochiai D, Abe Y, Fukutake M, Sato Y, Ikenoue S, Kasuga Y, et al.
Tissue Cell
. 2020 Dec;
68:101472.
PMID: 33360545
The use of mesenchymal stem cell sheets is a promising strategy for skin regeneration. The injection of dissociated human amniotic fluid stem cells (hAFSCs) was recently found to accelerate cutaneous...
4.
Sato Y, Ochiai D, Abe Y, Masuda H, Fukutake M, Ikenoue S, et al.
Stem Cell Res Ther
. 2020 Jul;
11(1):300.
PMID: 32690106
Background: Despite recent advances in neonatal care, sepsis remains a leading cause of mortality in neonates. Mesenchymal stem cells derived from various tissues, such as bone marrow, umbilical cord, and...
5.
Abe Y, Ochiai D, Masuda H, Sato Y, Otani T, Fukutake M, et al.
Stem Cells Transl Med
. 2019 Aug;
8(11):1170-1179.
PMID: 31407874
Despite the poor prognosis associated with myelomeningocele (MMC), the options for prenatal treatments are still limited. Recently, fetal cellular therapy has become a new option for treating birth defects, although...
6.
Fukutake M, Ochiai D, Masuda H, Abe Y, Sato Y, Otani T, et al.
Hum Cell
. 2018 Dec;
32(1):51-63.
PMID: 30506493
Adult wound healing can result in fibrotic scarring (FS) characterized by excess expression of myofibroblasts and increased type I/type III collagen expression. In contrast, fetal wound healing results in complete...
7.
Otani T, Ochiai D, Masuda H, Abe Y, Fukutake M, Matsumoto T, et al.
Pediatr Res
. 2018 Aug;
85(1):97-104.
PMID: 30120407
Background: Hypoxic-ischemic encephalopathy (HIE) remains a major cause of cerebral palsy. Increasing evidence has suggested that mesenchymal stem cells have a favorable effect on HIE. However, the efficacy of human...
8.
Ochiai D, Masuda H, Abe Y, Otani T, Fukutake M, Matsumoto T, et al.
Keio J Med
. 2018 Mar;
67(4):57-66.
PMID: 29515049
Mesenchymal stem cells (MSCs) have generated great interest in the fields of regenerative medicine and immunotherapy because of their unique biological properties. Among MSCs, amniotic fluid stem cells (AFS) have...
9.
Prenatal diagnosis of thrombosed dural sinus malformation with periorbital hemangioma: a case report
Ochiai D, Miyakoshi K, Miwa T, Fukutake M, Kasuga Y, Matsumoto T, et al.
Eur J Obstet Gynecol Reprod Biol
. 2015 Nov;
198:157-159.
PMID: 26603566
No abstract available.
10.
Matsumoto T, Miyakoshi K, Fukutake M, Ochiai D, Minegishi K, Tanaka M
J Med Ultrason (2001)
. 2015 Nov;
42(3):445-6.
PMID: 26576802
No abstract available.